Local Bevacizumab Treatment of Juvenile-Onset Respiratory Papillomatosis Might Induce Multiple Tracheal Pyogenic Granulomas

Laryngoscope. 2021 Feb;131(2):E518-E520. doi: 10.1002/lary.28928. Epub 2020 Jul 7.
No abstract available

Keywords: Recurrent respiratory papillomatosis; adverse effect; bevacizumab; laryngeal application; pyogenic granuloma.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Mucosal
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / administration & dosage
  • Bevacizumab / adverse effects*
  • Bevacizumab / therapeutic use
  • Child, Preschool
  • Female
  • Granuloma, Pyogenic / chemically induced*
  • Humans
  • Laryngoscopy
  • Papillomavirus Infections / drug therapy*
  • Respiratory Tract Infections / drug therapy*
  • Tracheal Diseases / chemically induced*

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab

Supplementary concepts

  • Recurrent respiratory papillomatosis